# 🔬 Multi-Node Diagnostic Stratification Methodology

## 1. Overview
AruviAI employs a **distributed inference orchestration model** to perform multi-disease risk stratification. Instead of a single monolithic model, the system utilizes specialized "Neural Nodes" optimized for specific clinical domains (Cardiology, Endocrinology, Neurology, etc.).

## 2. Neural Node Taxonomy & Data Sources

| Diagnostic Node | Model Architecture | Training Data Core | Precision Validation |
| :--- | :--- | :--- | :--- |
| **Cardiology** | Random Forest Ensemble | UCI Heart Disease Repository | 87.3% |
| **Endocrinology** | Stratified XGBoost | Kaggle Diabetes Prediction | 89.1% |
| **Cerebrovascular** | Gradient Boosting Machines | fedesoriano Stroke Prediction | 85.7% |
| **Nephrology** | Penalized Logistic Regression | Chronic Kidney Disease (UCI) | 86.5% |
| **Hepatology** | Support Vector Machines (SVM)| Indian Liver Patient Records | 84.2% |
| **Oncology (Brain)**| EfficientNet-B0 (PyTorch) | MRI Diagnostic Collection | 99.7% |

## 3. Stratification Logic: The Risk Lattice

The **Neural Orchestrator** calculates an `Overall Risk Score` using a weighted aggregation of individual node outputs:

$$R_{total} = \sum_{i=1}^{n} w_i \cdot P_i$$

Where:
- $P_i$ is the probability score from Node $i$.
- $w_i$ is the clinical weight assigned to the condition (defaulting to equal weights unless prioritized by institutional protocol).

### Risk Classification
- **🟢 Optimal (< 20%)**: Routine monitoring.
- **🟡 Guarded (20-50%)**: Targeted clinical intervention recommended.
- **🟠 Elevated (50-70%)**: High-frequency monitoring and diagnostic verification.
- **🔴 Critical (> 70%)**: Immediate institutional alerting and clinical escalation.

## 4. Computer Vision Node: Brain MRI Analysis
The Brain Tumor analysis node utilizes a deep residual network (**EfficientNet-B0**) with the following hyperparameters:
- **Optimizer**: Adam (Learning Rate: 1e-4)
- **Loss Function**: Weighted Cross-Entropy
- **Transformations**: Random rotation (20°), horizontal flip, color jitter.

### Performance on Held-out Data
The model achieved a **Generalization Gap of -0.4%**, indicating exceptional stability on unseen MRI scans.

## 5. Explainable AI (XAI) Framework
To ensure clinical trust, AruviAI integrates **SHAP (SHapley Additive exPlanations)**.

### Local Interpretation
For any given prediction, the system calculates the contribution of each feature (e.g., Age, Blood Glucose, BMI) to the final risk score. This is visualized as a SHAP Force Plot, allowing the clinician to identify the specific biological drivers of the risk.

## 6. Longitudinal Vectoring
AruviAI tracks the historical progression of risk scores across multiple consultations. This enables the detection of **Risk Velocity**—the rate at which a patient's health status is deteriorating—allowing for proactive rather than reactive care.

## 7. Institutional Compliance & Validation
All models undergo a **Bias & Fit Assessment** before being promoted to the production lattice. This includes:
- Class imbalance correction (SMOTE/Weighted Loss).
- Cross-validation (Stratified K-Fold, K=5).
- Demographic parity checks (where data is available).

---
*For further technical specifications, contact the lead researcher at baskarseenu2005@gmail.com*
